search
Back to results

PINS Stimulator System for Patients With Treatment Resistant Depression

Primary Purpose

Treatment-Resistant Depression

Status
Unknown status
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Deep Brain Stimulation
Sponsored by
Beijing Pins Medical Co., Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Treatment-Resistant Depression

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subject is aged ages 20-70 years
  2. Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by DSM-IV-TR criteria
  3. First episode onset before age 45
  4. Current episode > 12 months duration
  5. In the current episode: Documented resistance (i.e. persistence of the major depressive episode) to a minimum of 4 adequate depression treatments from at least 3 different treatment categories (e.g. SSRI's)
  6. SNRI's, TCA's, MAO-inhibitors, Mirtazipine, Nefazodone, Trazodone, Bupropion, lithium augmentation, thyroid augmentation, ECT); Adequacy of treatments as defined by a score of at least 3 according to the amended Antidepressant Treatment History Form (ATHF) criteria
  7. Hamilton Depression Rating Scale (HDRS) of > 20 at 3 separate baseline visits, rated by 2 separate psychiatrists, Baseline 2 and Baseline 3 HDRS scores cannot improve ≥ 25%

Exclusion Criteria:

  1. Patients with hearing impairment
  2. Failures of important organs and in severe conditions
  3. Be reluctant or disabled to receive neuropsychological assessments;
  4. Participate in other clinical trial
  5. Has a life expectancy of < 1 year
  6. The investigator and/or enrollment review committee, would preclude participation in the study

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    Deep Brain Stimulation

    Placebo

    Arm Description

    Stimulation is on

    Stimulation is off

    Outcomes

    Primary Outcome Measures

    Changes in the Hamilton Depression Rating Scale-17

    Secondary Outcome Measures

    The incidence of all adverse events

    Full Information

    First Posted
    September 27, 2014
    Last Updated
    October 13, 2016
    Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02253355
    Brief Title
    PINS Stimulator System for Patients With Treatment Resistant Depression
    Official Title
    PINS Stimulator System for Patients With Treatment Resistant Depression
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 2016 (undefined)
    Primary Completion Date
    December 2018 (Anticipated)
    Study Completion Date
    December 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Evaluate the effects and safety of Deep Brain Stimulation (DBS) to treat on patients with Treatment-Resistant Depression (TRD) and using functional magnetic resonance imaging (fMRI)to evaluate the influence of acupuncture on patients, which will be afford objective evidence for the mechanism of Acupuncture on depression.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Treatment-Resistant Depression

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Early Phase 1
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Deep Brain Stimulation
    Arm Type
    Experimental
    Arm Description
    Stimulation is on
    Arm Title
    Placebo
    Arm Type
    Sham Comparator
    Arm Description
    Stimulation is off
    Intervention Type
    Device
    Intervention Name(s)
    Deep Brain Stimulation
    Other Intervention Name(s)
    PINS Stimulator System
    Primary Outcome Measure Information:
    Title
    Changes in the Hamilton Depression Rating Scale-17
    Time Frame
    1, 3, 6 and 12 months of stimulation
    Secondary Outcome Measure Information:
    Title
    The incidence of all adverse events
    Time Frame
    1, 3, 6 and 12 months of stimulation

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Subject is aged ages 20-70 years Diagnosed with non-psychotic major depressive disorder, single or recurrent episode by DSM-IV-TR criteria First episode onset before age 45 Current episode > 12 months duration In the current episode: Documented resistance (i.e. persistence of the major depressive episode) to a minimum of 4 adequate depression treatments from at least 3 different treatment categories (e.g. SSRI's) SNRI's, TCA's, MAO-inhibitors, Mirtazipine, Nefazodone, Trazodone, Bupropion, lithium augmentation, thyroid augmentation, ECT); Adequacy of treatments as defined by a score of at least 3 according to the amended Antidepressant Treatment History Form (ATHF) criteria Hamilton Depression Rating Scale (HDRS) of > 20 at 3 separate baseline visits, rated by 2 separate psychiatrists, Baseline 2 and Baseline 3 HDRS scores cannot improve ≥ 25% Exclusion Criteria: Patients with hearing impairment Failures of important organs and in severe conditions Be reluctant or disabled to receive neuropsychological assessments; Participate in other clinical trial Has a life expectancy of < 1 year The investigator and/or enrollment review committee, would preclude participation in the study
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jia Fumin, PhD
    Phone
    +86 010-59361265
    Email
    pins_medical@163.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Li Luming, PhD
    Organizational Affiliation
    Tsinghua University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    PINS Stimulator System for Patients With Treatment Resistant Depression

    We'll reach out to this number within 24 hrs